Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

BWXT Hosting Investor Day on Nov. 16

15 November 2021

(LYNCHBURG, Va. – Nov. 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) is hosting an Investor Day 8:30 a.m. to approximately 11:30 a.m. ET on Tuesday, Nov. 16, 2021.


BWXT Names Robb A. LeMasters as Next Chief Financial Officer

05 November 2021

Current CFO David Black to Retire After 30 Years at BWXT and Serve as Special Advisor to CEO.


OPG awards contract for complex parts for nuclear refurbishment

04 November 2021

Peterborough – Ontario Power Generation (OPG) and BWX Technologies, Inc. (NYSE: BWXT) are announcing a contract for Fuelling Machine (FM) head engineering and component supply as part of refurbishment of the Darlington Nuclear Generating Station.



BWXT Awarded $21 Billion Environmental Management Contract for DOE’s Savannah River Site

28 October 2021

(LYNCHBURG, Va. – Oct. 28, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Savannah River Site (SRS) in South Carolina.


BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

16 September 2021

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.


BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

19 August 2021

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.



BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

10 May 2021

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.


Archive

Tags

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800
hjsimmons@bwxt.com

BWXT Canada Ltd.  

Natalie Cutler 
+1 519.620.5288 
nacutler@bwxt.com 

BWXT Nuclear Energy Canada Inc.

Natalie Cutler
+1 519.620.5288  
nacutler@bwxt.com 

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141
lebailey@nuclearfuelservices.com